Adicet Bio Inc.

ACET | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.93

-$0.25 (-2.72%)

At close: Sep 21, 2026, 4:00 PM ET

$9.12

+$0.19 (+2.07%)

Pre-market: Sep 22, 2026, 8:57 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $83.48M

Enterprise Value $-21.86M

Beta 1.59

Average Volume 95.49K

Shares Outstanding (Diluted) 10.75M

Shares Change YoY 88.76%

Institutional Ownership 59.10%

Exchange NASDAQ

ISIN US0070022076

Price Performance

Price Change 1M -1.9%

Price Change 3M 9.6%

Price Change 6M 31.1%

Price Change YTD 1.3%

Price Change 1Y -32.0%

Price Change 3Y -61.8%

Price Change 5Y -92.7%

1M CAGR (ann.) 11.9%

1Y CAGR (ann.) -31.1%

5Y CAGR (ann.) -40.5%

All-Time CAGR -46.1%

Valuation

PE Ratio -0.78

Forward PE N/A

PEG Ratio -0.01

Forward PEG 0.02

PS Ratio N/A

Forward PS 2.90

PB Ratio 0.69

P/FCF Ratio -0.98

P/Adj. FCF Ratio -0.87

P/OCF Ratio -1.13

EV/Sales N/A

EV/EBIT 0.22

EV/EBITDA 0.24

EV/FCF 0.26

Earnings Yield -128.2%

FCF Yield -101.8%

Adj. FCF Yield -114.9%

Financial Health

Net Cash $118.19M

Total Debt $12.85M

Cash & Short-Term Investments $118.19M

Total Assets $148.17M

Current Ratio 6.71

Quick Ratio 6.71

Debt / Equity Ratio 0.11

Debt / EBITDA -0.14

Debt / FCF -0.15

OCF / Debt -6.58

Interest Coverage -1,280.36

Altman Z-Score -5.78

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -12.9%

Returns

Return on Assets -66.8%

Return on Equity -74.9%

Return on Invested Capital -78.0%

Return on Capital Employed -79.7%

Return on Tangible Assets -66.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -100.0%

Revenue CAGR 10Y 2.9%

EPS CAGR 3Y 59.7%

EPS CAGR 5Y 15.3%

EPS CAGR 10Y 0.4%

FCF CAGR 3Y 4.1%

FCF CAGR 5Y -8.6%

FCF CAGR 10Y -17.0%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 12

EPS Growth Next 3Y 40.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 3, 2026

EPS Estimate (next Q) -$1.56

EPS Growth Est (next Q) -66.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $27

Price Target Upside 202.4%

Cash Flow

Operating Cash Flow $-84.53M

Free Cash Flow $-84.97M

Adj. Free Cash Flow $-95.89M

FCF Per Share -$7.91

OCF Per Share -$7.87

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-1.34M

Operating Income $-103.71M

EBITDA $-91.82M

Net Income $-98.97M

EPS (Diluted) -$11.45

Revenue / Employee N/A

Profit / Employee $-970.33K

Employees 102